Month: February 2021

A University of Texas at Arlington researcher has received an Office of Naval Research (ONR) grant to examine the mechanics of how blast-like events cause damage to the brain. Ashfaq Adnan, professor of mechanical and aerospace engineering, has received a three-year, $944,845 grant to study the potential link between blast-like trauma and cellular and tissue
0 Comments
Students in Saundra Murphys third grade class participate in silent reading at the start of class on the first day of instruction at Weaverville Elementary School on Monday, Aug. 17, 2020 in Weaverville, CA. Kent Nishimura | Los Angeles Times | Getty Images Elementary school-aged children will likely be able to receive Covid-19 vaccinations early
0 Comments
Today, the U.S. Food and Drug Administration approved Nulibry (fosdenopterin) for injection to reduce the risk of death due to Molybdenum Cofactor Deficiency Type A, a rare, genetic,  metabolic disorder that typically presents in the first few days of life, causing intractable seizures, brain injury and death. Today’s action marks the first FDA approval for
0 Comments
Susan Moore, MD, tragically passed away from COVID-19 in December. Before she died, she complained to her son that she was being mistreated by the medical staff because she is Black. She said that her doctors were doubtful of her complaints of worsening symptoms and dismissive of her requests for pain medication. She said they
0 Comments
A year into the coronavirus pandemic, life in America remains almost unrecognizable. Noses and mouths remain hidden in public, gatherings remain verboten in many states, kitchen and dining room tables still function as work cubicles and classrooms, and take-out still subs for a night on the town. How long will the world stay this way?
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. And then there were three. The US Food and Drug Administration (FDA) today granted emergency use authorization (EUA) to the Ad26.COV2.S vaccine from Janssen/Johnson & Johnson (J&J) for people 18 and older after reviewing its safety and efficacy data. More vaccine
0 Comments
Brian J. Gerber, Arizona State University and Melanie Gall, Arizona State University After one month in office, the Biden administration has fundamentally changed how the federal government responds to the COVID-19 pandemic. In direct contrast to his predecessor, President Joe Biden is treating this as a national-scale crisis requiring a comprehensive national strategy and federal
0 Comments
Feb. 26, 2021 — After several weeks of declining, COVID-19 numbers are back on the rise and new variants continue to emerge, according to White House officials — just as states begin to lift restrictions and open doors to restaurants and businesses. CDC Director Rochelle Walensky, MD, reported during a Friday COVID-19 briefing that coronavirus cases and
0 Comments
NEW BRUNSWICK, N.J., February 26, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend Emergency Use Authorization (EUA) for the Company’s single-shot COVID-19 vaccine candidate for adults 18 and older, developed by the Janssen Pharmaceutical
0 Comments
On Wednesday, the FDA announced that the Johnson and Johnson coronavirus vaccine was safe, more effective on serious cases of Covid-19 than on more moderate cases, and totally protective against hospitalizations and death.  Today, the independent group of infectious disease professionals that advises the FDA on whether a vaccine should receive a thumb’s up or
0 Comments
An FDA advisory panel lent their support today to a rapid clearance for Janssen/Johnson & Johnson’s COVID-19 vaccine. The Food and Drug Administration (FDA) is expected to quickly provide an emergency use authorization (EUA) for the vaccine following the recommendation by the panel. The FDA’s Vaccines and Related Biological Products Advisory Committee voted 22-0 on
0 Comments
by Sarah Kwon This story also ran on NBC News. For a decade, Jennifer Crow has taken care of her elderly parents, who have multiple sclerosis. After her father had a stroke in December, the family got serious in its conversations with a retirement community — and learned that one service it offered was covid-19
0 Comments
In early December, Dr. Katy Stephenson was watching TV with her family and scrolling through Twitter when she saw a tweet that made her shout. “I said ‘Oh, my God!’ ” she recalled. “Super loud. My kids jumped up. My husband looked over. He said, ‘What’s wrong, what’s wrong, is everything OK?’ I was like, ‘No, no, it’s
0 Comments
Preterm labor comprises 12.7% of all pregnancies. Although the overall rate of pregnancy is decreasing, the occurrence of premature birth due to preterm labor in south korea has been increasing over the past 7 years. Not only is preterm birth accountable for about a half of all neonatal mortality cases, the neurological deficits in surviving
0 Comments
FDA Approves Amondys 45 (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 45 CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) —  Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Amondys
0 Comments
People wait in line for coronavirus disease (COVID-19) vaccinations at Martin Luther King Jr. Community Hospital in Willowbrook, Los Angeles, California, February 25, 2021. Lucy Nicholson The U.S. is “nowhere close” to achieving herd immunity from Covid, and more transmissible variants mean even more people will need to get vaccinated to reach it, a CDC
0 Comments
While the amazing regenerative power of the liver has been known since ancient times, the cells responsible for maintaining and replenishing the liver have remained a mystery. Now, research from the Children’s Medical Center Research Institute at UT Southwestern (CRI) has identified the cells responsible for liver maintenance and regeneration while also pinpointing where they
0 Comments
Satjit Bhusri, MD, is worried about heart health, his own, and yours. A long-time New York City cardiologist, he is now treating the aftereffects of Covid-19. “What’s unusual about COVID…is that it is extremely inflammatory. That means the body attacks [the virus], and [the immune system] kind of goes overboard,” he said. What is unnerving
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two research teams have identified a new coronavirus variant in New York City and across the Northeast that could evade natural immune responses and some monoclonal antibody treatments, according to CNN. The variant, called B.1.526, has appeared in diverse neighborhoods in
0 Comments
22 February 2021 — AstraZeneca today announced the voluntary withdrawal of the Imfinzi (durvalumab) indication in the US for previously treated adult patients with locally advanced or metastatic bladder cancer. This decision was made in consultation with the Food and Drug Administration (FDA). In May 2017, Imfinzi was granted accelerated approval in the US based on promising
0 Comments
maralixibat Treatment for Cholestatic Pruritus in Patients with Alagille Syndrome Mirum Pharmaceuticals Announces Completion of Rolling NDA Submission for Maralixibat in Alagille Syndrome FOSTER CITY, Calif.–(BUSINESS WIRE)–Feb. 1, 2021– Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced it has completed submission of its rolling New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for maralixibat for the
0 Comments